Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement AgencyNovember 25, 2019
Press Release
Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx™100October 1, 2019
Press Release
Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12thSeptember 5, 2019
Press Release
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth ConferenceJuly 29, 2019
Press Release
Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBDJune 3, 2019